胸膜间皮瘤的临床试验
总计27539个结果
-
Åslaug HellandBristol-Myers Squibb; Oslo University Hospital; Ultimovacs ASA主动,不招人癌症 | 间皮瘤 | 胸膜间皮瘤 | 肺癌 | 癌症,肺 | 间皮瘤;胸膜 | 间皮瘤;肺挪威, 丹麦, 瑞典, 西班牙, 澳大利亚
-
RS Oncology LLC招聘中
-
National Cancer Institute (NCI)招聘中
-
Ain Shams University完全的
-
University of California, IrvineBeckman Laser Institute University of California Irvine撤销
-
National Cancer Institute (NCI)撤销恶性胸膜间皮瘤 (Mpm) | 恶性胸腔积液 (Mpe) | 上皮性肿瘤,恶性 | 胸腔积液,恶性 | 间皮素 (Msln)美国
-
NRG OncologyNational Cancer Institute (NCI)终止胸膜双相间皮瘤 | 胸膜上皮样间皮瘤 | I 期胸膜恶性间皮瘤 AJCC v8 | IA 期胸膜恶性间皮瘤 AJCC v8 | IB 期胸膜恶性间皮瘤 AJCC v8 | II 期胸膜恶性间皮瘤 AJCC v8 | IIIA 期胸膜恶性间皮瘤 AJCC v8美国, 加拿大
-
University of ChicagoNational Cancer Institute (NCI)主动,不招人双相间皮瘤 | 上皮样间皮瘤 | 腹膜恶性间皮瘤 | 胸膜双相间皮瘤 | 胸膜上皮样间皮瘤 | 胸膜恶性间皮瘤 | 胸膜肉瘤样间皮瘤 | 复发性腹膜恶性间皮瘤 | 复发性胸膜恶性间皮瘤 | 肉瘤样间皮瘤美国
-
European Organisation for Research and Treatment...ETOP IBCSG Partners Foundation完全的肺癌的任何阶段(任何组织型) | 恶性胸膜间皮瘤的任何阶段 | 任何胸腺恶性肿瘤的任何阶段西班牙, 比利时, 爱尔兰, 斯洛文尼亚, 法国, 英国, 波兰, 意大利, 瑞士
-
Gruppo Oncologico Italiano di Ricerca Clinica招聘中
-
National Cancer Institute (NCI)主动,不招人双相间皮瘤 | 上皮样间皮瘤 | III 期胸膜恶性间皮瘤 AJCC v7 | I 期胸膜恶性间皮瘤 AJCC v7 | IA 期胸膜恶性间皮瘤 AJCC v7 | IB 期胸膜恶性间皮瘤 AJCC v7 | II 期胸膜恶性间皮瘤 AJCC v7美国
-
National Cancer Institute (NCI)终止
-
Mario Negri Institute for Pharmacological Research完全的
-
The Netherlands Cancer InstituteMerck Sharp & Dohme LLC招聘中
-
Health Pharma Professional Research撤销
-
Swansea University完全的
-
National Cancer Institute (NCI)完全的非小细胞肺癌 | 转移到肺或胸膜的非胸部癌症 | Advanced Esophageal Cancers | Primary Small Cell Lung Cancers | Pleural Mesotheliomas美国
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital终止
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)招聘中
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC终止
-
Abramson Cancer Center at Penn Medicine招聘中
-
Istituto Clinico Humanitas完全的MALIGNANT PLEURAL MESOTHELIOMA意大利
-
University of PennsylvaniaNational Cancer Institute (NCI); Biogen完全的
-
Ontario Clinical Oncology Group (OCOG)Novartis Pharmaceuticals终止
-
Instituto Nacional de Cancerologia de MexicoNational Council of Science and Technology, Mexico未知
-
TCR2 TherapeuticsBristol-Myers Squibb主动,不招人卵巢癌 | 非小细胞肺癌 | 间皮瘤 | 间皮瘤,恶性 | 胆管癌 | 非小细胞肺癌转移 | 胸膜间皮瘤 | 腹膜间皮瘤 | 间皮瘤;胸膜 | 复发性胆管癌 | 高级别卵巢浆液性腺癌美国, 加拿大
-
PrECOG, LLC.AstraZeneca; University of Sydney; Thoracic Oncology Group Australasia (TOGA)主动,不招人
-
University College, LondonCancer Research UK完全的
-
National Cancer Institute (NCI)主动,不招人
-
Targovax OyTheradex未知确定 ONCOS-102 联合化疗的安全性、耐受性和疗效西班牙, 法国